In vitro experiments to improve the AD model mice show that BMSCs-EXO miR-146a reduces the level of NF-κB and promotes the recovery of astrocyte functions, such as synaptogenesis and correction of cognitive dysfunction [80]. The gene discussed is NFKB1; the disease is Alzheimer disease.